awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q57106864-7C1331F3-624B-4241-9CFE-1D9D06DF9FEE
Q57106864-7C1331F3-624B-4241-9CFE-1D9D06DF9FEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57106864-7C1331F3-624B-4241-9CFE-1D9D06DF9FEE
Novel treatment strategies for patients with HER2-positive breast cancer who do not benefit from current targeted therapy drugs
P2860
Q57106864-7C1331F3-624B-4241-9CFE-1D9D06DF9FEE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57106864-7C1331F3-624B-4241-9CFE-1D9D06DF9FEE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7cff7a3431dbcf3f6ffbb4b7ef6e2a3d4e145dba
P2860
FDA Approval of Palbociclib in Combination with Fulvestrant for the Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer.